Kissing Viabahn VBX stent graft reconstruction of thoracic central veins for management of superior vena cava syndrome

被引:1
作者
Shin, David S. [1 ,2 ]
Jackson, Tyler R. [1 ]
Bertino, Frederic J. [3 ]
Monroe, Eric J. [4 ]
Hage, Anthony N. [5 ]
Lee, Eunjee [6 ]
Ingraham, Christopher R. [1 ]
Vaidya, Sandeep [1 ]
Chick, Jeffrey Forris Beecham [1 ,2 ]
机构
[1] Univ Washington, Sect Vasc & Intervent Radiol, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA
[2] Univ Washington, Deep Vein Inst, Seattle, WA 98195 USA
[3] Emory Univ, Div Intervent Radiol & Image Guided Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA
[4] Univ Wisconsin, Dept Radiol, Sect Vasc & Intervent Radiol, Madison, WI 53706 USA
[5] Thomas Jefferson Univ, Dept Radiol, Div Intervent Radiol, Philadelphia, PA 19107 USA
[6] Chungnam Natl Univ, Dept Informat & Stat, Daejeon, South Korea
关键词
Stent graft reconstruction; Stent reconstruction; Superior vena cava syndrome; SVC syndrome; Thoracic central venous occlusive disease; VBX; Viabahn; ENDOVASCULAR TREATMENT; OBSTRUCTION; PLACEMENT; BENIGN; CHEMOTHERAPY; STANDARDS; SOCIETY;
D O I
10.1016/j.jvsv.2022.05.008
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: In the present study, we evaluated the technical and clinical outcomes of thoracic central vein reconstruction for superior vena cava (SVC) syndrome using kissing Viabahn VBX stent grafts (W.L. Gore & Associates, Flagstaff, AZ). Methods: All adult patients with SVC syndrome who had undergone attempted bilateral brachiocephalic vein-to-SVC reconstruction using kissing VBX stent grafts at an academic hospital between August 2019 and February 2021 were reviewed. The technical results, adverse events, imaging follow-up findings, and clinical outcomes were recorded. Patency over time was assessed using Kaplan-Meier analysis. Results: A total of 28 patients (16 women and 12 men; mean age, 52.0 years) constituted the study cohort. Of the 28 patients, 17 (60.7%) had had benign and 11 (39.3%) malignant etiologies. The presenting symptoms included neck swelling (n =17; 60.7%), bilateral upper extremity swelling (n =15; 53.6%), dyspnea (n = 7; 25%), unilateral upper extremity swelling (n = 4;14.3%), and dysphagia (n =1; 3.6%). SVC reconstruction with VBX stent grafts in a kissing configuration was successfully completed in 27 of the 28 patients (96.4%). Four major adverse events were noted in the benign etiology subgroup (23.5%), including intraprocedural hemopericardium (n = 3) and delayed pneumothorax (n = 1). Of the 28 patients, 27 (96.4%) had experienced resolution of their presenting symptoms. The mean clinical follow-up for the living patients was 358.8 +/- 77.2 days (range, 78-645 days). The mean imaging follow-up for the living patients was 272.6 +/- 91 days (range, 26-594 days). The primary, primary-assisted, and secondary patency rates at 12 months were 71.8%, 88.8%, and 100%, respectively. Conclusions: For the management of SVC syndrome, thoracic central vein reconstruction with kissing VBX stent grafts was feasible with a high rate of symptom resolution and acceptable patency. However, this technique should not be recommended for those with benign SVC syndrome owing to the high risk of cardiac tamponade.
引用
收藏
页码:1279 / +
页数:10
相关论文
共 28 条
  • [1] Bardet Jeremy, 2018, Open J Cardiovasc Surg, V10, p1179065218771900, DOI 10.1177/1179065218771900
  • [2] Percutaneous stenting of supyerior vena cava syndrome: Treatment outcome in patients with benign and malignant etiology
    Barshes, Neal R.
    Annambhotla, Suman
    El Sayed, Hosam F.
    Huynh, Tam T.
    Kougias, Panagiotis
    Dardik, Alan
    Lin, Peter H.
    [J]. VASCULAR, 2007, 15 (05) : 314 - 321
  • [3] Bierdrager E, 2005, NETH J MED, V63, P20
  • [4] Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up
    Breault, Stephane
    Doenz, Francesco
    Jouannic, Anne-Marie
    Qanadli, Salah Dine
    [J]. EUROPEAN RADIOLOGY, 2017, 27 (01) : 97 - 104
  • [5] Covered Stent Placement for the Treatment of Malignant Superior Vena Cava Syndrome: Is Unilateral Covered Stenting Safe and Effective?
    Cho, Younghoon
    Gwon, Dong Il
    Ko, Gi-Young
    Ko, Heung Kyu
    Kim, Jin Hyoung
    Shin, Ji Hoon
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2014, 15 (01) : 87 - 94
  • [6] Dinkel HP, 2003, J ENDOVASC THER, V10, P788, DOI 10.1583/1545-1550(2003)010<0788:ETOMSV>2.0.CO
  • [7] 2
  • [8] Society of Interventional Radiology Reporting Standards for Thoracic Central Vein Obstruction
    Dolmatch, Bart L.
    Gurley, John C.
    Baskin, Kevin M.
    Nikolic, Boris
    Lawson, Jeffrey H.
    Shenoy, Surendra
    Saad, Theodore F.
    Davidson, Ingemar
    Baerlocher, Mark O.
    Cohen, Emil I.
    Dariushnia, Sean R.
    Faintuch, Salomao
    d'Othee, Bertrand Janne
    Kinney, Thomas B.
    Midia, Mehran
    Clifton, James
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (04) : 454 - 460
  • [9] Superior vena cava obstruction: Bypass using spiral vein graft
    Doty, JR
    Flores, JH
    Doty, DB
    [J]. ANNALS OF THORACIC SURGERY, 1999, 67 (04) : 1111 - 1116
  • [10] Endovascular Treatment of Malignant Superior Vena Cava Syndrome: Results and Predictive Factors of Clinical Efficacy
    Fagedet, Dorothee
    Thony, Frederic
    Timsit, Jean-Francois
    Rodiere, Mathieu
    Monnin-Bares, Valerie
    Ferretti, Gilbert R.
    Vesin, Aurelien
    Moro-Sibilot, Denis
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 36 (01) : 140 - 149